We are live on ! Find out more
DIM

DLK Investment Management Portfolio holdings

AUM $235M
1-Year Est. Return 12.41%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+12.41%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$235M
AUM Growth
+$15.6M
Cap. Flow
+$5.27M
Cap. Flow %
2.24%
Top 10 Hldgs %
38.85%
Holding
113
New
7
Increased
49
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$790K
2
MKC icon
McCormick & Company Non-Voting
MKC
+$583K
3
AAPL icon
Apple
AAPL
+$435K
4
SPSB icon
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
+$432K
5
NVDA icon
NVIDIA
NVDA
+$416K

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.83M
2
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$392K
3
MSFT icon
Microsoft
MSFT
+$226K
4
JBHT icon
JB Hunt Transport Services
JBHT
+$115K
5
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$100K

Sector Composition

Rank Sector Weight
1 Technology 19.46%
2 Healthcare 16.18%
3 Consumer Staples 12.99%
4 Industrials 12.88%
5 Financials 12.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMDW icon
101
Revolution Medicines Inc Warrant
RVMDW
$128M
$14.1K 0.01%
77,000
– –
BNGO icon
102
Bionano Genomics
BNGO
$13.7M
$13.7K 0.01%
+206
New +$15.4K
OMIC
103
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$12.9K 0.01%
833
– –
AREN icon
104
Arena Group
AREN
$76.2M
$12.7K 0.01%
+10,800
New +$16.1K
AKTS
105
DELISTED
Akoustis Technologies Inc
AKTS
$12.7K 0.01%
21,500
– –
AUROW
106
Aurora Innovation Warrant
AUROW
$303M
$10.3K ﹤0.01%
38,262
– –
ME
107
DELISTED
23andMe Holding Co
ME
$8.7K ﹤0.01%
817
+50
+7% +$643
NUTX
108
Nutex Health
NUTX
$1.14B
$3.67K ﹤0.01%
255
+133
+109% +$2.68K
PRST
109
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$1.74K ﹤0.01%
+10,000
New +$2.79K
EMB icon
110
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
– –
-4,396
Closed -$392K
NKTX icon
111
Nkarta
NKTX
$167M
– –
-12,320
Closed -$81.3K
QTTB icon
112
Q32 Bio
QTTB
$459M
– –
-3,333
Closed -$36.5K
BCEL
113
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
– –
-89,000
Closed -$11.7K
1 2 3 4
5

Similar funds

CF
CNA Financial Chicago, Illinois $235M AUM 3.39% 1-Year Est. Return
JRPCML
J. R. Prunier Capital Management LLC Holden, Massachusetts $235M AUM
CWL
Causey Wealth LLC Greenwood Village, Colorado $236M AUM 14.5% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
BWM
Bernard Wealth Management Royal Oak, Michigan $234M AUM 27.82% 1-Year Est. Return
SP
Saranac Partners London $234M AUM 14.11% 1-Year Est. Return
AL3A
Accel Leaders 3 Associates Palo Alto, California $234M AUM
TCM
Tekne Capital Management New York $237M AUM 62.98% 1-Year Est. Return

DLK Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, DLK Investment Management held 113 positions worth $235M, up 7.1% from $220M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

DLK Investment Management's Q1 2024 filing shows 7 new, 49 increased, 12 reduced and 4 closed positions. Its largest new stake was NVIDIA: 5,740 shares worth $519K. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.83M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • DLK Investment Management's largest Q1 2024 buy was NVIDIA: 5,740 shares worth $519K.
  • DLK Investment Management added most to Medtronic in Q1 2024, an estimated $790K increase.
  • DLK Investment Management's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.83M.
  • DLK Investment Management fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $392K.
  • DLK Investment Management's ten largest holdings make up 39% of its $235M portfolio in Q1 2024.
  • DLK Investment Management opened 7 new positions and closed 4 in Q1 2024.
  • DLK Investment Management's portfolio value rose 7.1% quarter-over-quarter to $235M.

Based on DLK Investment Management's 13F filing for Q1 2024, filed 12 Apr 2024.